Printer Friendly

Browse Clinical trials topic

Articles

1-300 out of 600 article(s) nextnext page
Title Author Type Date Words
Bascom Palmer doses first US patient with X-Linked Retinitis Pigmentosa in Nightstar gene therapy clinical trial. Sep 20, 2018 254
Zealand Pharma achieves primary and key secondary endpoints in phase three trial assessing dasiglucagon. Sep 20, 2018 189
Zealand Pharma achieves primary and key secondary endpoints in phase three trial assessing dasiglucagon. Sep 20, 2018 193
Fasenra Shows Consistent Safety and Sustained Efficacy in Long-Term Phase III BORA Trial in Severe Eosinophilic Asthma. Sep 19, 2018 312
DFB Soria Completes a Phase 2 Clinical Trial of Submicron Particle Paclitaxel Anhydrous Ointment for Actinic Keratosis. Sep 19, 2018 512
Agenus awarded USD5m in milestone payment for initiation of Phase 1 trial of LAG-3 antibody. Sep 18, 2018 148
Zealand Pharma achieves endpoints in Phase 3 trial with dasiglucagon. Sep 18, 2018 217
Cannabis stocks in focus after Tilray gets DEA approval to import cannabis drug. Sep 18, 2018 553
Oramed wins US FDA clearance for IND application for ORMD-0901 to treat type 2 diabetes. Sep 18, 2018 202
Actelion Pharmaceuticals reveals results of first randomised controlled trial in portopulmonary hypertension. Sep 18, 2018 145
Agenus awarded USD5m in milestone payment for initiation of Phase 1 trial of LAG-3 antibody. Sep 18, 2018 152
Oramed wins US FDA clearance for IND application for ORMD-0901 to treat type 2 diabetes. Sep 18, 2018 198
Actelion Pharmaceuticals reveals results of first randomised controlled trial in portopulmonary hypertension. Sep 18, 2018 141
Tilray announces U.S. DEA approval to import medical cannabis study drug. Sep 18, 2018 223
IMV Inc announces initial data from Phase 2 trial of DPX-Survivac with Keytruda. Sep 18, 2018 202
Iterum Therapeutics initiates two Phase 3 clinical trials for sulopenem. Sep 18, 2018 112
AstraZeneca's Lumoxiti (moxetumomab pasudotox-tdfk) gains USFDA approval for certain patients with relapsed or refractory hairy cell leukaemia. Sep 17, 2018 235
AstraZeneca's Lumoxiti (moxetumomab pasudotox-tdfk) gains USFDA approval for certain patients with relapsed or refractory hairy cell leukaemia. Sep 17, 2018 231
Allergan plc announces positive results from clinical study of higher dose of BOTOX Cosmetic in patients with glabellar lines. Clinical report Sep 17, 2018 278
Allergan plc announces positive results from clinical study of higher dose of BOTOX Cosmetic in patients with glabellar lines. Clinical report Sep 17, 2018 274
Menlo Therapeutics initiates enrollment in second Phase 3 trial of serlopitant. Sep 17, 2018 169
Argenx reports Phase 2 proof-of-concept clinical trial of efgartigimod. Sep 17, 2018 362
Cro Service For Clinical Trial Effect Of Adjuvant Treatment With N-acetylcysteine. Sep 17, 2018 116
Kiniksa presents Phase 1a/1b data for KPL-716 in atopic dermatitis. Sep 15, 2018 301
Incyte announces Phase 2b trial of ruxolitinib cream met primary endpoint. Sep 13, 2018 372
Spectrum expands poziotinib trial into first-line therapy, doses first patient. Sep 12, 2018 321
Natera reports 'several million dollar agreement' for clinical trial. Sep 12, 2018 119
Spectrum Pharmaceuticals Expands Poziotinib Clinical Trial into First-Line Therapy and Doses First Patient. Sep 12, 2018 413
Atreca Raises USD 125m to Expand its Preclinical Pipeline and Advance its First Program into Clinical Trials. Sep 12, 2018 141
Verrica Pharmaceuticals announces results from Phase 2 VP-102 trial. Financial report Sep 12, 2018 365
Innovent Biologics treats first patient under phase III clinical trial of sintilimab for non-squamous non-small cell lung cancer (NSCLC). Sep 11, 2018 266
Innovent Biologics treats first patient under phase III clinical trial of sintilimab for non-squamous non-small cell lung cancer (NSCLC). Sep 11, 2018 262
Merck: Phase 3 clinical study of ZERBAXA met pre-specified primary endpoints. Clinical report Sep 11, 2018 158
United States : Early stage clinical trial of antimalarial drug begins. Sep 11, 2018 474
Innovent announces CFDA IND approval for Anti-CD47 Antibody IBI188. Sep 10, 2018 235
Innovent announces CFDA IND approval for Anti-CD47 Antibody IBI188. Sep 10, 2018 231
Five Prime Therapeutics Completes Phase 1 Safety Lead-In and Initiates Phase 3, Global Registrational Trial of Bemarituzumab in Front-Line Advanced Gastric and Gastroesophageal Junction Cancers. Sep 10, 2018 581
Amicus: FDA says current package not sufficient for accelerated AT-GAA approval. Sep 10, 2018 435
Cyclacel Pharmaceuticals initiates Phase 2 trial of sapacitabine with olaparib. Sep 10, 2018 166
Eli Lilly initiates IXORA-R head-to-head clinical trial. Clinical report Sep 10, 2018 164
Feasibility Studies To Build Collaborative Partnerships In Cancer Research (p20 Clinical Trial Not Allowed). Sep 9, 2018 238
United States : Sangamo Announces 16 Week Clinical Results Including Reductions In Glycosaminoglycans In Phase 1/2 Trial Evaluating SB-913, A Zinc Finger Nuclease Genome Editing Treatment For MPS II (Hunter Syndrome). Financial report Sep 9, 2018 675
QLHC reports new randomized, investigational I-SPY 2 TRIAL of olaparib and durvalumab for breast cancers. Sep 7, 2018 246
QLHC reports new randomized, investigational I-SPY 2 TRIAL of olaparib and durvalumab for breast cancers. Sep 7, 2018 242
Compugen announces first patient dosed with COM701 in Phase 1 clinical trial. Sep 7, 2018 139
United States : Athenex Announces Positive Recommendation by the Drug Safety Monitoring Board Upon the Second Interim Analysis and to Continue the Oraxol Phase III Program. Sep 7, 2018 334
United States : Pfizer Terminates Domagrozumab (PF-06252616) Clinical Studies for the Treatment of Duchenne Muscular Dystrophy. Clinical report Sep 6, 2018 347
United States : Life Sciences Companies Move to Veeva Vault CTMS for Greater Visibility and Speed in Clinical Trials. Sep 6, 2018 456
United States : Clinical trial testing topical cream plus influenza vaccine in progress. Sep 6, 2018 461
Kineta Launches First-in-Human Clinical Trial of LHF-535 for Lassa Fever. Sep 6, 2018 314
argenx doses first patient in global Phase 3 registration trial of efgartigimod for gMG. Sep 6, 2018 177
Redx receives UK support to re-start phase 1/2a clinical study for RXC004. Clinical report Sep 6, 2018 153
argenx doses first patient in global Phase 3 registration trial of efgartigimod for gMG. Sep 6, 2018 173
Redx receives UK support to re-start phase 1/2a clinical study for RXC004. Clinical report Sep 6, 2018 149
Verastem doses first patient in Phase 1/2 trial of cancer combination candidate. Sep 6, 2018 126
Synthetic Biologics, Cedars-Sinai enter agreement for clinical study of SYN-010. Sep 6, 2018 310
Replimune gets FDA acceptance of IND application for RP1. Sep 6, 2018 263
Eurofins completes acquisition of Clinical Research Laboratories in North America. Sep 5, 2018 203
CytoSorbents' REFRESH 2-AKI Protocol revisions wins US FDA's approval. Sep 5, 2018 220
CytoSorbents' REFRESH 2-AKI Protocol revisions wins US FDA's approval. Sep 5, 2018 216
ProQR Therapeutics announces interim results from QR-110 clinical trial. Financial report Sep 5, 2018 119
Histogenics' NoeCart did not meet primary endpoint of Phase 3 trial. Sep 5, 2018 260
RA Pharmaceuticals completes Phase 2 FDA interactions, designs Phase 3 program. Sep 5, 2018 194
Tyme Technologies exceeds enrollment expectations for Phase 2 SM-88 trial. Sep 5, 2018 144
BioCardia announces additional data from Phase III CardiAmp heart failure trial. Sep 5, 2018 161
Celsion reaches enrollment for Phase 3 OPTIMA study. Clinical report Sep 5, 2018 117
Neurotrope, Nemours collaborate to initiate clinical trial in Fragile X syndrome. Sep 5, 2018 270
JAMA publishes Phase III study using 22nd Century's SPECTRUM cigarettes. Clinical report Sep 5, 2018 317
Mati Therapeutics Interim Phase II Nepafenac Clinical Trial Results Signal Significant Post-op Pain Reduction in Cataract Surgery Patients. Sep 5, 2018 343
Inovio reports first patient dosed in hepatitis C vaccine Phase 1 study. Sep 4, 2018 179
Pieris announces dosing of first patient in Phase 1 combination trial. Sep 4, 2018 209
Opko Health initiates Phase 2 trial of Rayaldee. Sep 4, 2018 163
Arrowhead Completes Dosing in Phase 1 Study of ARO-AAT for Treatment of Alpha-1 Liver Disease. Sep 4, 2018 282
Nextism reveals results of supplementary Phase III E-FIT trial. Sep 3, 2018 238
Pfizer to halt two trials for treatment of Duchenne muscular dystrophy. Sep 3, 2018 154
Nextism reveals results of supplementary Phase III E-FIT trial. Sep 3, 2018 234
Pfizer to halt two trials for treatment of Duchenne muscular dystrophy. Sep 3, 2018 150
Positive Interim Safety Data In Phase 3 ALS Trial. Clinical report Sep 3, 2018 201
Preliminary Results From Phase 3 Heart Failure Trial. Sep 3, 2018 648
Stem Cell Therapy Meets Safety, Efficacy Endpoints In GvHD Trial. Sep 3, 2018 424
Positive Interim Safety Data In Phase 3 ALS Trial. Clinical report Sep 3, 2018 201
Preliminary Results From Phase 3 Heart Failure Trial. Sep 3, 2018 648
Stem Cell Therapy Meets Safety, Efficacy Endpoints In GvHD Trial. Sep 3, 2018 424
Testing for Sudbury--made cancer tool begins: RNA Diagnostics, Inc. announces clinical trial for breast cancer monitoring tool. McKinley, Karen Sep 1, 2018 1023
Risk factors for hepatitis C: A clinical study. Gupta, Sonu; Sodhi, Surender; Brar, Gursimrat; Bansal, Ravinder Clinical report Sep 1, 2018 4313
Clinical Trial Finds Telos95 Supports Cellular Health. Sep 1, 2018 247
Gender Differences in Heart Disease: Some risk factors are unique to females, and women are less likely to be studied in clinical trials. Sep 1, 2018 701
AstraZeneca updates on TULIP 1 Phase III trial for anifrolumab. Aug 31, 2018 251
AstraZeneca updates on TULIP 1 Phase III trial for anifrolumab. Aug 31, 2018 247
JHL Biotech Receives Positive CHMP Scientific Advice for Global Phase III Clinical Trial of Proposed Bevacizumab Biosimilar to Treat Lung Cancer. Aug 31, 2018 476
Singapore's First Clinical Trial Approval for T-cell Engineered (TCR) Immunotherapy for Treatment of Liver Cancer. Aug 31, 2018 475
AstraZeneca reports Phase 3 anifrolumab trial did not meet primary endpoint. Aug 31, 2018 137
Arrowhead completes dosing in Phase 1 study of ARO-AAT. Aug 31, 2018 156
United States : Update on TULIP 1 Phase III trial for anifrolumab in systemic lupus erythematosus. Aug 31, 2018 181
Pfizer Terminates Domagrozumab Clinical Studies for the Treatment of Duchenne Muscular Dystrophy. Clinical report Aug 31, 2018 563
Eagle Pharmaceuticals Concludes Enrollment of Second Safety and Efficacy Study at Hajj to Evaluate Ryanodex for Exertional Heat Stroke. Clinical report Aug 31, 2018 688
Sophiris Bio provides update of Phase 2b localised prostate cancer trial. Aug 30, 2018 262
Eagle Pharmaceuticals concludes enrollment of second Ryanodex study. Clinical report Aug 30, 2018 267
Pfizer terminates domagrozumab clinical studies for the treatment of DMD. Clinical report Aug 30, 2018 304
First Subject Dosed In Phase 1 Trial Evaluating INP105 for the Treatment Of Acute Agitation In Bipolar I Disorder And Schizophrenia. Aug 30, 2018 616
Sophiris Bio Updates on Phase 2b Localized Prostate Cancer Trial Following Patient Death. Aug 30, 2018 599
Tenax Therapeutics: New Clinical Study Publication Results Indicate Levosimendan Offers Renal Protective Benefits to Heart Failure Patients. Clinical report Aug 29, 2018 476
Arena reports presentation of Phase 1 clinical data for ralinepag. Aug 28, 2018 103
Esperion announces Phase 3 bempedoic acid/ezetimibe study meets endpoints. Clinical report Aug 27, 2018 310
FDA Grants Fast Track Designation for Phase 3 Trial of Inhaled Xenon Gas Therapy. Aug 27, 2018 469
Roche receives FDA Approval for Cobas EGFR Mutation Test v2 as Companion Diagnostic with Iressa in First-Line Treatment of Patients with Non-Small Cell Lung Cancer. Aug 27, 2018 378
The Grant Will Support Operations And Phase 2a Development Of Avid100, A Highly Potent Anti-egfr Antibody-drug Conjugate. Aug 25, 2018 446
Laser treatment trial could help cancer sufferers. Aug 25, 2018 653
AstraZeneca provides update on AERISTO Phase IIIb trial for Bevespi Aerosphere in chronic obstructive pulmonary disease. Aug 24, 2018 216
FDA grants fast track designation to Mallinckrodt and NPXe's phase 3 trial of inhaled xenon gas therapy. Aug 24, 2018 246
AstraZeneca reports top-line results from AERISTO phase IIIb trial for Bevespi Aerosphere in COPD. Aug 24, 2018 260
AstraZeneca provides update on AERISTO Phase IIIb trial for Bevespi Aerosphere in chronic obstructive pulmonary disease. Aug 24, 2018 212
FDA grants fast track designation to Mallinckrodt and NPXe's phase 3 trial of inhaled xenon gas therapy. Aug 24, 2018 242
Mallinckrodt & NPXe partnership passes US FDA's Fast Track Designation for Phase 3 trial of inhaled xenon gas therapy. Aug 24, 2018 267
Mallinckrodt & NPXe partnership passes US FDA's Fast Track Designation for Phase 3 trial of inhaled xenon gas therapy. Aug 24, 2018 263
Pfizer, Astellas Amend Clinical Research Protocols for Two Phase 3 Trials of Enzalutamide in Patients with Hormone-Sensitive Prostate Cancer. Clinical report Aug 24, 2018 296
Service Contract - Search For Expert Trainers For Specific Training In Clinical Studies. Clinical report Aug 24, 2018 102
Novaremed Has Raised CHF 6m to Prepare for a Phase 2b Clinical Study in Diabetic Neuropathic Pain. Clinical report Aug 24, 2018 361
AstraZeneca reports top-line results from AERISTO phase IIIb trial for Bevespi Aerosphere in COPD. Aug 24, 2018 264
Kala Pharmaceuticals announces FDA approval of Inveltys. Aug 23, 2018 129
Imago BioSciences Completes Enrollment in Phase 1/2a Study of IMG-7289 in Acute Myeloid Leukemia and Myelodysplastic Syndrome. Report Aug 23, 2018 320
COMPASS to begin Psilocybin Therapy clinical trial in patients with treatment-resistant depression following the US FDA approval. Aug 23, 2018 202
Merck signs clinical trial collaboration agreement with Rexahn Pharmaceuticals. Aug 23, 2018 181
Can-Fite BioPharma enrols and doses first patient in phase three Piclidenoson Comfort trial. Aug 23, 2018 165
ALK-Abello announces acceptance of review of its registration application for tree SLIT-tablet in Europe. Brief article Aug 23, 2018 281
COMPASS to begin Psilocybin Therapy clinical trial in patients with treatment-resistant depression following the US FDA approval. Aug 23, 2018 198
Merck signs clinical trial collaboration agreement with Rexahn Pharmaceuticals. Aug 23, 2018 177
Can-Fite BioPharma enrols and doses first patient in phase three Piclidenoson Comfort trial. Aug 23, 2018 161
Pfizer, Astellas amend clinical research protocols for two Phase 3 enzalutamide trials. Aug 23, 2018 254
Pfizer, Astellas amend clinical research protocols for two Phase 3 enzalutamide trials. Aug 23, 2018 250
Sensorion to commence phase two trial of SENS-401. Aug 22, 2018 169
Sensorion to commence phase two trial of SENS-401. Aug 22, 2018 165
Veristat Congratulates Alnylam on the FDA Approval of Onpattro. Aug 22, 2018 252
Pfizer, Astellas amend clinical research protocols for two phase 3 trials. Clinical report Aug 22, 2018 227
MC2 Therapeutics Touts Positive Top-line Results from Phase 3 Clinical Trial Comparing MC2-01 Cream to Taclonex in Adults with Psoriasis. Aug 22, 2018 567
Wishaw man's drug trial blow; Ged refused new MND treatment. Aug 22, 2018 472
Biosceptre reports launch of Phase 1 clinical trial of first-in-class oncology vaccine BIL06v. Aug 22, 2018 288
Biosceptre reports launch of Phase 1 clinical trial of first-in-class oncology vaccine BIL06v. Aug 22, 2018 284
Vitamin D on glycaemia control in type 2 diabetes patients: A systematic review of randomised clinical trials. Yu, Xue Fei; Zaslawaki, Christopher; Lim, Chi Eung Danforn Aug 22, 2018 7323
The effectiveness of manual lymphatic drainage and low level laser in the treatment of a client with lipedema: an N-of-1 trial. Balinski, Angela; Grace, Sandra; Avila, Cathy; Bradbury, Jo Aug 22, 2018 1462
AbbVie signs clinical research collaboration with Tolero Pharmaceuticals. Aug 21, 2018 200
Viela Bio begins first clinical trial of VIB9600 in healthy adult volunteers. Aug 21, 2018 186
AbbVie signs clinical research collaboration with Tolero Pharmaceuticals. Aug 21, 2018 196
Viela Bio begins first clinical trial of VIB9600 in healthy adult volunteers. Aug 21, 2018 182
Xeris Pharmaceuticals, OHSU Conducting Artificial Pancreas Clinical Trial Using Xeris' Novel Ready-to-Use Liquid Glucagon. Aug 21, 2018 643
Tolero Pharmaceuticals Forges Clinical Research Collaboration with AbbVie for Acute Myeloid Leukemia Trial. Aug 21, 2018 483
Singapore's Health Sciences Authority approves Lion TCR's Phase I/II multicentre clinical study of LioCyx. Aug 20, 2018 169
Tolero Pharmaceuticals signs clinical research collaboration with AbbVie. Aug 20, 2018 171
Lion TCR Pte Ltd approves first clinical trial for T cell engineered (TCR) immunotherapy in Singapore for treatment of liver cancer. Aug 20, 2018 284
Singapore's Health Sciences Authority approves Lion TCR's Phase I/II multicentre clinical study of LioCyx. Aug 20, 2018 173
Lion TCR Pte Ltd approves first clinical trial for T cell engineered (TCR) immunotherapy in Singapore for treatment of liver cancer. Aug 20, 2018 288
Tolero Pharmaceuticals signs clinical research collaboration with AbbVie. Aug 20, 2018 175
Viela Bio begins clinical trials months after $250M spinoff. Aug 20, 2018 444
Trovagene Completes Second Dosing Cohort of Patients Treated with Onvansertib in Ongoing Phase 1b/2 AML Trial. Aug 17, 2018 859
Biohaven Reports Positive Results from Double-Blind, Placebo-Controlled, Investigator Initiated, Proof Of Concept Trial Of BHV-0223 For Anxiety. Financial report Aug 17, 2018 745
Agenus Receives Second Milestone Payment from Merck as Phase I Clinical Trial Launches. Aug 17, 2018 242
Abeona reports draft version of EB-101 Phase 3 trial protocol posted prematurely. Clinical report Aug 17, 2018 108
Xeris Pharmaceuticals, OHSU conduct artificial pancreas clinical trial. Aug 17, 2018 228
Inovio Pharmaceuticals commences PENNVAX-GP randomised clinical trial. Aug 16, 2018 273
Inovio Pharmaceuticals commences PENNVAX-GP randomised clinical trial. Aug 16, 2018 269
Biohaven says BHV-0223 proof of concept clinical trial met primary endpoint. Aug 16, 2018 305
Clementia Pharmaceuticals completes enrollment in Phase 3 MOVE Trial for FOP. Aug 16, 2018 126
Regeneron, Teva announce 'positive' topline Phase 3 fasinumab results. Clinical report Aug 16, 2018 211
Trovagene completes second dosing of Phase 1b/2 trial of AML candidate. Aug 16, 2018 155
Iovance Biotherapeutics announces clinical trial updates with collaborators. Aug 16, 2018 151
Oragenics resumes Phase 2 clinical trial of AG013. Aug 15, 2018 305
CEL-SCI says IDMC recommends continuation of Phase 3 head and neck cancer study. Aug 15, 2018 136
Izana Bioscience Initiates Namilumab Phase II Proof-of-Concept Clinical Study in Ankylosing Spondylitis. Clinical report Aug 15, 2018 333
Izana Bioscience commenced phase II proof-of-concept clinical study of ankylosing spondylitis drug namilumab. Clinical report Aug 15, 2018 163
Izana Bioscience commenced phase II proof-of-concept clinical study of ankylosing spondylitis drug namilumab. Clinical report Aug 15, 2018 159
Samsung Bioepis to Initiate Phase 1 Clinical Trial of SB26 Ulinastatin-Fc Fusion Protein. Aug 14, 2018 257
Realm Therapeutics reports preliminary data from Phase 2 trial of PR022. Aug 14, 2018 142
Aveo announces acceptance of CANbridge IND application for CAN017 trial. Aug 14, 2018 121
Electromed 'thrilled' by results of independent clinical study. Clinical report Aug 14, 2018 149
Orphazyme reports enrolment of first patient in phase III clinical trial of arimoclomol for ALS. Aug 13, 2018 246
Orphazyme reports enrolment of first patient in phase III clinical trial of arimoclomol for ALS. Aug 13, 2018 242
Celltrion Enters into Phases 1 and 3 Clinical Trials for the Adalimumab Biosimilar 'CT-P17'. Aug 13, 2018 302
Checkpoint says clinical data on CK-101 selected for presentation at IASLC. Aug 13, 2018 172
Unum Therapeutics announces IND activation for ACTR T cells with trastuzumab. Aug 13, 2018 124
United States : Sesen Bio Announces Vicinium Granted Fast Track Designation by FDA for Treatment of Non-muscle Invasive Bladder Cancer. Aug 13, 2018 299
Phase 2 Clinical Trial Of Ischemic Stroke Therapy Launched In China. Clinical report Aug 13, 2018 205
First Patient In Phase 3 Study Of Multistem Treatment For Ischemic Stroke. Aug 13, 2018 496
Twelve-Month Update For Clinical Trial In Severe SCI. Aug 13, 2018 237
Sweden : Investigator-initiated phase II clinical study of remetinostat started in patients with basal cell carcinoma. Report Aug 9, 2018 199
First Patient Dosed with AMC303 in Phase Ib Extension Cohort Based on Positive Safety Results. Aug 8, 2018 426
Sangamo's candidate for Hemophilia A shows positive Phase 1/2 safety data. Aug 8, 2018 154
AnaptysBio expects to report Phase 2a asthma data in Q3. Clinical report Aug 7, 2018 125
BioLineRx says 'extremely encouraged' by lead-in period of Phase 3 GENESIS trial. Aug 7, 2018 296
Madrigal sees 'high likelihood of success' for Phase 3 MGL-3196 study. Aug 7, 2018 167
TG Therapeutics completes target enrollment in ULTIMATE Phase 3 Trials in MS. Aug 7, 2018 106
Viveve announces FDA approval to continue VIVEVE II clinical study. Aug 7, 2018 157
Bellerophon says DMC recommends stopping Phase 3 INOvation-1 study of INOpulse. Aug 7, 2018 384
u.s cancer trial is ellen's dream; Mum Claire pins hopes for brave tot, 3, on clinical research bid. Aug 7, 2018 708
United Kingdom : Clinical Trials Regulation. Aug 7, 2018 942
Ovid Therapeutics says Phase 2 STARS Trial of OV101 achieved primary endpoint. Clinical report Aug 6, 2018 583
Phase 2 Clinical Trial Of The hemic St unched In China. Clinical report Aug 6, 2018 205
First Patient: In Phase 3 Study Of Multistem Treatment For Ischemic Stroke. Aug 6, 2018 496
Twelve-Month Update For Asterias' Clinical Trial In Severe SCI. Aug 6, 2018 237
Phase 2 Clinical Trial Of Ischemic Stroke Therapy Launched In China. Clinical report Aug 6, 2018 205
First Patient: In Phase 3 Study Of Multistem Treatment For Ischemic Stroke. Aug 6, 2018 496
Twelve-Month Update For Asterias' Clinical Trial In Severe SCI. Aug 6, 2018 237
Clinical Research of Pulmonary Langerhans Cell Histiocytosis in Children. Wang, Dong; Cui, Lei; Li, Zhi-Gang; Zhang, Li; Lian, Hong-Yun; Ma, Hong-Hao; Zhao, Yun-Ze; Zhao, Xia Report Aug 5, 2018 3683
Marken opens new Melbourne clinical trial logistics hub. Aug 3, 2018 143
Marken opens new Melbourne clinical trial logistics hub. Aug 3, 2018 139
Bonti Announces Completion of Phase 2a Scar Reduction Clinical Study. Clinical report Aug 3, 2018 543
CalciMedica treats first patients with CM4620 in acute pancreatitis clinical study. Clinical report Aug 2, 2018 204
Nicox begins Phase 2 study of NCX 470 in open-angle glaucoma and ocular hypertension. Aug 2, 2018 230
CalciMedica treats first patients with CM4620 in acute pancreatitis clinical study. Clinical report Aug 2, 2018 200
Nicox begins Phase 2 study of NCX 470 in open-angle glaucoma and ocular hypertension. Aug 2, 2018 226
Emergent BioSolutions starts phase one clinical study to assess ZIKV-IG. Aug 2, 2018 148
Emergent BioSolutions starts phase one clinical study to assess ZIKV-IG. Aug 2, 2018 144
Takeda Touts New Phase 3 Data on Investigational Subcutaneous Formulation of Vedolizumab in Moderately to Severely Active Ulcerative Colitis. Aug 2, 2018 311
New England Journal of Medicine has Publishes Emmaus Life Sciences Endari Phase 3 Trial Results. Aug 2, 2018 715
Bristol-Myers Squibb, Gritstone Oncology Forge Clinical Research Collaboration to Evaluate Novel Immunotherapy Approach in Advanced Solid Tumors. Aug 2, 2018 610
Spring Bank Pharmaceuticals announces 'positive' results from Phase 2 ACHIEVE. Financial report Aug 2, 2018 456
United States : Governor Wolf Announces New Apprenticeships for Clinical Research, Residential Electricians. Aug 2, 2018 521
Theravance Biopharma reports 'positive' data from Phase 2 trial of TD-9855. Aug 1, 2018 218
BioLineRx initiates Phase 1/2a clinical study for AGI-134. Clinical report Aug 1, 2018 179
Denali announces 'positive' clinical results from Phase 1 DNL201 study. Report Aug 1, 2018 234
From Randomized Controlled Trials to the Real World: Putting Evidence into Context. Blonde, Lawrence; Dendy, Jared A.; Skolnik, Neil; White, John R. Clinical report Aug 1, 2018 4715
The Economic Impact of Clinical Research in an Italian Public Hospital: The Malignant Pleural Mesothelioma Case Study. Ippoliti, Roberto; Falavigna, Greta; Grosso, Federica; Maconi, Antonio; Randi, Lorenza; Numico, Gian Aug 1, 2018 8007
Development and Pre-clinical Study of Anti-Allergic Cream Containing Dexamethasone and Chlorpheniramine/Deksametazon ve Klorfeniramin Iceren Anti-alerjik Kremlerin Gelistirilmesi ve Klinik Oncesi Calismasi. Pham, Duy Toan; Nguyen, Ngoc Nha Thao Clinical report Aug 1, 2018 3816
Comparative Clinical Study of the Effectiveness of MEKRITEN in Patients with Chronic Suppurative Otitis/Kronik Supuratif Otitis Mediali Hastalarda MEKRITEN Etkinliginin Karsilastirmali Klinik Calismasi. Mukhitdinov, Abror; Olimov, Nemat; Olimova, Shirinkhan Clinical report Aug 1, 2018 3493
A Randomized Trial of Off-Site Collaborative Care for Depression in Chronic Hepatitis C Virus. Kanwal, Fasiha; Pyne, Jeffrey M.; Tavakoli-Tabasi, Shahriar; Nicholson, Susan; Dieckgraefe, Brian; S Clinical report Aug 1, 2018 7131
Estimation of Population Average Treatment Effects in the FIRST Trial: Application of a Propensity Score-Based Stratification Approach. Chung, Jeanette W.; Bilimoria, Karl Y.; Stulberg, Jonah J.; Quinn, Christopher M.; Hedges, Larry V. Report Aug 1, 2018 8356
Verona Pharma begins Phase 2 clinical trial evaluating nebulised RPL554 as add-on therapy. Aug 1, 2018 232
Verona Pharma begins Phase 2 clinical trial evaluating nebulised RPL554 as add-on therapy. Aug 1, 2018 228
GE Healthcare, Lantheus Start Phase 3 Clinical Trial of Investigational Agent for the Detection of Coronary Artery Disease. Aug 1, 2018 438
180 Therapeutics Touts Positive Results from a Phase 2a Clinical Trial of Anti-TNF Therapy in Dupuytren's Disease. Aug 1, 2018 573
Cerecor enrolls first patient in Phase I trial for nOH in Parkinson's disease. Aug 1, 2018 101
Proclara Biosciences Initiates Clinical Trial of NPT189 for Systemic Amyloidoses. Jul 31, 2018 175
We were shocked by position of higher education, former health ministers in Clinical Trial Law: MP Mostafa Kamal El-Din Hussein. Jul 31, 2018 1751
JHL Biotech Receives Positive CHMP Scientific Advice for Global Phase III Clinical Trial of Proposed Rituximab Biosimilar. Jul 31, 2018 278
JHL Biotech Announces China Approves Clinical Trial Rituximab Biosimilar to Treat Non-Hodgkin Lymphoma. Jul 31, 2018 276
The First Successful Uterus Transplantation in the Mena Region Under Clinical Research. Jul 31, 2018 365
Lantheus, GE Healthcare start Phase 3 trial of Flurpiridaz F. Jul 31, 2018 200
ARCA Biopharma announces 'positive' outcome of End-of-Phase 2 meeting with FDA. Jul 31, 2018 388
Clinical Research Organization For Study going. Jul 31, 2018 113
Source Strengthning And Pump House Raw Water Rising Main Raw Water Pumping Machinery Water Treatment Plant Pure Water Rising Main Pure Water Pumping Machinery Rcc Esr Distribution System Trial Run And. Jul 30, 2018 193
A CLINICAL STUDY ON HIV-TB CO-INFECTION. Mathew, Sheela; Sandeep Report Jul 30, 2018 3813
First U.S. Patients Treated In Phase 2 CLI Trial. Jul 30, 2018 256
Clinical Research Organization (cro) Per Estudi Going "regorafenib Followed By Nicolumab In Patients With Hepatocellullar Carcinoma Progressin Under Sorafenib". Jul 29, 2018 133
United States : PPD Expands Central Labs Preclarus Technology, Helping Clients Accelerate and Enhance Clinical Research Decision-making. Jul 28, 2018 411
Medivir sees positive results from MIV-711 Phase IIa extension study. Jul 27, 2018 255
Medivir sees positive results from MIV-711 Phase IIa extension study. Jul 27, 2018 251
Eton Pharma's Phase III Trial of EM-100 Ophthalmic Solution Yields Positive Results. Jul 27, 2018 160
Sandoz receives European Commission approval for biosimilar Hyrimoz. Jul 27, 2018 133
Germany : Bayer receives approval for Kovaltry in China for the treatment of children and adults with Hemophilia A. Jul 27, 2018 155
Japan : Eisai and Biogen Announce Detailed Results of Phase Ii Clinical Study of Ban2401 in Early Alzheimers Disease at Alzheimers Association International Conference (Aaic) 2018. Conference news Jul 27, 2018 473
Japan : Eisai and Biogen Present Detailed Results From Phase Ii Clinical Study of Elenbecestat in Mci and Mild to Moderate Alzheimers Disease at Alzheimers Association International Conference (Aaic) 2018. Conference news Jul 27, 2018 717
Destiny Pharma reports positive data from Phase 1 skin irritation study. Jul 26, 2018 222
Destiny Pharma reports positive data from Phase 1 skin irritation study. Jul 26, 2018 218
Eisai and Biogen Present Detailed Results from Phase II Clinical Study of Elenbecestat in MCI and Mild to Moderate Alzheimer's Disease at AAIC 2018. Clinical report Jul 26, 2018 1582
Eisai and Biogen Announce Detailed Results of Phase II Clinical Study of BAN2401 in Early Alzheimer's Disease at AAIC 2018. Clinical report Jul 26, 2018 2217
US FDA Grants Approval of Orilissa (elagolix) for Management of Moderate to Severe Pain Associated with Endometriosis. Jul 26, 2018 231
Aldeyra Therapeutics Enrolls First Patient in Phase 3 Clinical Trial of Reproxalap for Treatment of Ichthyosis in SjA[pilcrow sign]gren-Larsson Syndrome. Jul 26, 2018 312
United States : NIH-funded researchers present preliminary clinical trial results suggesting aggressive blood pressure control may lower risk of cognitive impairment. Jul 26, 2018 253
NeuroVia begins Phase 1/2 clinical study of lead drug candidate NV1205 for childhood cerebral adrenoleukodystrophy treatment. Jul 25, 2018 305
NeuroVia begins Phase 1/2 clinical study of lead drug candidate NV1205 for childhood cerebral adrenoleukodystrophy treatment. Jul 25, 2018 301
Merck says Phase 3 KEYNOTE-048 trial met a primary endpoint. Jul 25, 2018 184
Merck: Phase 3 KEYNOTE-048 trial met primary endpoint of OS. Jul 25, 2018 175
ResTORbio announces 'positive' topline results in Phase 2b trial of RTB101. Jul 25, 2018 609
Cerprobe to commence Phase 3 study of lenabasum. Clinical report Jul 25, 2018 194
Biogen announces detailed results from Phase 2 study of elenbecestat. Clinical report Jul 25, 2018 411
Reagents, Control And Expendable Materials For Analyzers Of The Clinical Diagnostic Laboratory, Diagnostic Kits For General Clinical Research Of The Health Care Institution 4th City Childrens Clinical. Jul 25, 2018 171
Tonsillectomy pain control with IV dexamethasone, infiltrated dexamethasone and infiltrated bupivacaine; a randomised, double-blind, placebo controlled, prospective clinical trial. Jul 25, 2018 2700
SHORT COMMUNICATION - Clinical Trial Registry: An essential requirement for physical therapy and health researchers in Pakistan. Clinical report Jul 25, 2018 3788
Clinical Trial Registry in Pakistan. Jul 25, 2018 499
BeiGene starts Phase 3 trial for advanced gastric cancer. Jul 24, 2018 236
BeiGene starts Phase 3 trial for advanced gastric cancer. Jul 24, 2018 232
Omeros Doses First Cohort in Clinical Trial of Phosphodiesterase 7 Inhibitor Targeting Addiction. Jul 24, 2018 218
NEJM Publishes Results of Emmaus Life Sciences Phase 3 Trial of Endari in Sickle Cell Disease. Jul 24, 2018 334
Merck announces results from Phase 3 Drive-Forward clinical trial. Financial report Jul 24, 2018 117
BeiGene announces first patient dosed in Phase 3 trial of tislelizumab. Jul 24, 2018 109
United States : NIH expands program that conducts large-scale clinical trials in real-world settings. Jul 24, 2018 782
United States : NIH renews NeuroNEXT for neurological clinical research. Jul 24, 2018 346
United States : Sangamo Announces Treatment Of First Patient In Phase 1/2 Clinical Trial Evaluating SB-318 Investigational In Vivo Genome Editing Therapy For MPS I. Jul 24, 2018 468
Phase 3 Renal Outcomes Trial of Invokana Stopped Early Based on Positive Efficacy. Jul 23, 2018 320
Blade Therapeutics Commences Phase 1 Study of Calpain Inhibitor for Fibrosis. Jul 23, 2018 200
Acceleron reports preliminary results from Part 1 of ACE-083 Phase 2 trial. Financial report Jul 23, 2018 191
Celgene announces phase 3 combined Revlimid-Rituximab study. Clinical report Jul 23, 2018 149
First U.S. Patients Treated In Phase 2 CLI Trial. Jul 23, 2018 256
First U.S. Patients Treated In Phase 2 CLI Trial. Jul 23, 2018 257
Provision Of Experimental Drugs For The Double-blind Apis Clinical Trial Promoted By Public Assistance - Paris Hospitals (ap-hp). Jul 20, 2018 131
Sellas Life Sciences receives Fast Track designation for galinpepimut-S. Jul 20, 2018 182
Alligator Bioscience submits CTA application to start clinical phase I study in cancer patients with ATOR-1015. Report Jul 20, 2018 278
Alligator Bioscience files application for clinical phase I study of ATOR-1015 in cancer patients. Jul 20, 2018 216
Alligator Bioscience submits CTA application to start clinical phase I study in cancer patients with ATOR-1015. Report Jul 20, 2018 279
Alligator Bioscience files application for clinical phase I study of ATOR-1015 in cancer patients. Jul 20, 2018 217
Alligator Bioscience submits CTA application to start clinical phase I study in cancer patients with ATOR-1015. Report Jul 20, 2018 274
Alligator Bioscience files application for clinical phase I study of ATOR-1015 in cancer patients. Jul 20, 2018 212
Pulmatrix Releases Preliminary Results from Clinical Trial of Pulmazole in Subjects with Asthma. Jul 20, 2018 352
SOM Biotech Commences Phase 2a Clinical Trial of SOM3355 in Huntington's Disease. Jul 20, 2018 366
PainReform wins US FDA's approval for Phase III post-operative pain relief study of PRF-110. Jul 19, 2018 199
PainReform wins US FDA's approval for Phase III post-operative pain relief study of PRF-110. Jul 19, 2018 195
PainReform to conduct two pivotal Phase III clinical trials for post-operative pain relief after FDA approval. Jul 19, 2018 161
PainReform to conduct two pivotal Phase III clinical trials for post-operative pain relief after FDA approval. Jul 19, 2018 157
Allergan and Molecular Partners report 'positive' Phase 3 results for Abicipar. Jul 19, 2018 166
Cara Therapeutics doses first patient in Phase 2 trial of Korsuva for pruritus. Jul 19, 2018 173
Medtronic starts enrollment in trial for ECG Belt for heart failure therapy. Jul 19, 2018 258

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters